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Background
Intraoperative radiotherapy (IORT) is the application of a single dose of radiation to the tumor bed, possibly affected site, and lymphatic drainage area while the areas are exposed during surgery in a single session [1] . The single high dose in a single session can generate a biological effect 2-3 times that of fractionated radiations by external beam radiation therapy (EBRT) [2] . For example, 20 Gy of IORT generates biological effects comparable to that generated by 70 Gy of EBRT [3] . Moreover, by collaboration of surgeons and radiation therapists, IORT can be delivered immediately after the resection of tumor tissue and directly to the target region, thus shortening the interval between operation and radiation and decreasing the proliferation of tumor cells. Further, the radiation field can be precisely determined by moving or covering the normal tissues out of the field of vision, thus greatly reducing the harm to surrounding tissues and the incidence of radiation-related complications [4] [5] [6] .
Given the above advantages, IORT has been widely applied to the treatment of breast cancer, pancreatic cancer, gastric cancer, rectal cancer, and solitary metastatic brain tumor in recent years, and demonstrated its superiority [7] [8] [9] [10] [11] .
However, to our best knowledge, no application of IORT to invasive thymoma has been reported. Therefore, we recruited 14 patients from all the cases of stage II thymoma proved by pathological examination admitted to our hospital from September to December, 2016. The patients were administered radiation (8) (9) (10) (11) (12) Gy, median dose 10 Gy, 50KVe) for the tumor bed after radical surgery for thymoma, and the safety and short-term effectiveness of IORT were investigated.
Materials and Methods

Patients collection
Patients were collected from September to December, 2016.
For preliminary selection, the patients who consulted the Department of Thoracic Surgery in our hospital due to mediastinal mass and myasthenia gravis (MG) were considered candidate subjects of the current study. These candidates were confirmed with mediastinal mass by thoracic CT scanning and ruled out with remote metastasis, and planned to receive surgical treatment. For secondary selection, the patients meeting the following criteria were included. Intra-operative frozen section was confirmed as thymoma, tumor invasion to the capsule not to adjacent tissues or organs was observed with naked eyes, and the tumor was in stage II according to Masaoka 
Surgical procedures
The surgery was performed under intravenous anesthesia 
INTRABEAM IORT technique
IORT in the current study was realized by using INTRABEAM. INTRABEAM® treatment system (Carl Zeiss, Oberkochen, Germany, Figure 1 ) is a mobile miniature electron beam-driven device to deliver radiation directly to the tumor bed during surgery, with a flexible arm and a balanced stand [12] . It can provide a point source of low energy X-rays (50 kV max) at the tip of an electron beam drift tube (3.2 mm in diameter) fixed at the end of the manipulator. The tube is sheathed by a spherical applicator (ranged 1.5 to 5.0 cm in diameter) with a cone-shaped shank at the bottom, which is placed upside down during IORT [13, 14] . The low-energy X-rays are emitted after the electron beam hits the gold target at the tip of the tube and are modulated by the applicator to give a uniform dose in a spherical field [13] .
Based on the specific size of the tumor and tumor bed, an applicator in appropriate size was deployed above and against the tumor bed. A saline-soaked gauze was then folded into a shape of 2 cm in thickness, and the folded gauze was set around the applicator to block X-rays from entering the normal tissues and thus ensure the localization of radiation to the tumor bed area (Figure 2 ). Totally, a single dose of 8-10 Gy at the applicator surface was administered in the current study. The specific radiation time was determined by comprehensively considering the radiation dose, the depth of invasion and the size of the applicator. Different IORT parameters are shown in Table   1 . Table 2 .
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Results
General characteristics of patients
Complications related to IORT
During the surgery, the blood loss and rehydration are shown in 
Conditions of patients during the follow-up
During the follow-up, CT scanning of the lungs at 1 month after discharge revealed that 5 patients developed moderate pulmonary inflammation, of whom 1 had symptoms of cough and increased hemogram levels, and 2 had a small amount of pleural effusion. However, CT scanning of the lungs at 3 and 12 months after discharge showed that all the patients returned to normal, without cough, short of breath after activity, or pulmonary fibrosis surrounding the radiation field ( Figure 3 ). In addition, ultrasonic cardiography and ECG demonstrated no significant difference before and after surgery ( Table 3 ).
Effectiveness of intrabeam IORT
At the end of the follow-up, no relapse or remote metastasis had been found. Of the 5 patients with MG, 4 had symptoms significantly improved after treatment, while 1 did not show any obvious improvement in symptoms, presented with blepharoptosis and inability to comb hair, administered Neostigmine orally. 
Discussion
Thymoma is derived from thymic epithelium and accounts for approximately 50% of all types of anterior mediastinal tumor. Despite the fact that most thymoma is benign, thymoma has a potential of transforming into malignancy that will invade local tissue or metastasize to remote sites.
According to the statistics from the National Cancer Institute, the incidence of thymoma is 0.13 per 100,000 person-years in the United States [15] . In addition, over 30% of patients with thymoma has a comorbidity of MG [16] . Consistent with the previous report, MG was present in 5 of the 14 patients in the current study. Therefore, it is vitally important to treat thymoma properly.
Surgical removal of thymoma is the standard treatment for thymomas that can be completely excised. However, whether the tumor can be completely removed remains a problem and determines the prognosis of thymoma patients.
It has been reported that the completion of surgical resection is a factor that substantially affects local recurrence and survival [17] . According to the International Thymic Malignancy Interest Group (ITMIG), the complete resection can only be achieved by excising the whole thymus and surrounding tissue [18] .
To realize complete resection and enhance the effects of surgery, other treatments are also adjunctly used, such as post-operative radiotherapy (PORT). However, controversies still exist over the effectiveness of PORT for thymoma [19] . Some studies reported that radiotherapy could significantly improve the prognosis of patients with stage II or III thymoma [20] , and PORT is needed to decrease the local recurrence and increase the survival of patients with stage II or even more invasive thymoma [21] .
Other studies revealed that radiotherapy could only improve the prognosis of stage III patients rather than stage II [22] .
Increasing evidence supports the ineffectiveness of PORT in recent years. The rate of complete removal reached 88%
in stage II patients [23] , and the patients with thymic tumor completely resected did not benefit from PORT [24] . A meta-analysis by Korst tumor proliferation [30] . Furthermore, IOPT can inhibit local recurrence by changing the tumor microenvironment.
The exudates collected at the surgical wound in 24 h after breast-conserving surgery could stimulate the proliferation and migration of breast cancer cells in vitro, while the exudates from the wound that underwent IORT could not [30] . Although the single dose of IORT is much higher than that of EBRT, low-energy X rays have weak penetrating power; when the radiation dose for tumor bed was 20 Gy, the power would decrease to 5-7 Gy at 1 cm from the surface [12] . Deployment of the spherical radiation applicator at a certain distance from the skin and the thoracic wall can effectively reduce radiation injury, thus making radiation protection easier than EBRT. In the current study, we protected the normal tissues by covering the radiation applicator with a wet gauze of 2 cm in thickness.
After the surgery, we closely followed up the patients and Moreover, because thymoma is located in special places, generally near the heart and great vessels, intra-operative radiation may exert effects on the conduction system and the systolic and diastolic functions of the heart. We therefore compared the ultrasonic cardiograms before IORT with those after IORT at 6 months and 1 year, respectively.
No significant change was observed in the systolic and diastolic functions and chamber size of the heart, suggesting that IORT does not affect the cardiac functions.
Similarly, no obvious change was detected in electrocardiogram before and after surgery, indicating that IORT does not affect the cardiac conduction system.
In 
Conclusions
It is safe to administer INTRABEAM IORT at a dose of about 10 Gy with low energy to patients with stage II invasive thymoma. The INTRABEAM IORT does not significantly increase operation-or radiation-related complications, has no significant effect on the vital organs around the radiation field, such as lung and heart. The longterm efficacy is worth expecting.
